Well, certainly if you look at that diagram you can see we are down more than 10 billion over where we would have expected to be if we had stayed on that dotted green line which is the trajectory for nih going back to 1970 so it will take quite a bit to make up that ground. The other thing the other thing i might show you a consequence of that for people trying to get Research Funded that is the success rate, an investigator who has sent there grant in is facing. You can see going back a couple of decades that has been in the range of 25 to 35 percent. More recently we are down in the zone of 16 to 16 to 17 percent, which is very unhealthy and has caused a great deal of teefor. What is the number . One out of six would be funded at this time. How easy you turn away . Five out of six. What does that mean . I see where you are going a number of grants we find each year at the present time is about 9,000 which means we are turning away about 55,000. I do not think i can tell the differenc
16. Im happy to. Nkats, now just three years old, was the first new center at nih again, quite a long time and was focused in trying to identify the bottle necks from going from basic science discoveries to benefits. In collaboration with our partners in the private sector. I think initially there were some concerns that nih is becoming a drug company, that really was never the plan and is not happening now. Instead, we are identifying areas of Technology Development that no Single Company could undertake, but working with them, we can give you just one example. The effort to try to figure out when youre developing a new drug, whether its going to be safe in humans or not. Has been a real difficult one. We use animal studies, small animals, large animals. Its not that accurate. Its slow, its expensive. We probably lose drugs along the way because some mouse got a slight liver issue and it probably would have had no relevance to humans but we sort of lose the drug at that point. Wouldnt
Good to see you again. Thank you so much. Thank you. Look forward to be being here. [ inaudible ]. [ speaking spanish ]. Senator, very nice to meet you. [ inaudible ]. Small world. Very small. One more. Good morning, senator. Read your book. Big fan. Thank you. Can i get a picture here . How are you . Good. Which way . This way . Right here . Great. Thank you. Looking forward to hearing you. Thanks so much. Here . Right here. I got an extra egg. Senator, its good to see you again. Are you sitting there . Right next to madam speaker. The purpose of why were here today of course is to hear from the junior senator from that very warm state of florida, marco rubio. We truly had hoped that the senator might bring some of that Florida Weather with him but unfortunately, we are stuck with the new england cold and the snow. The senator is someone you may know. Hes the son of cuban immigrants. He was born and raised in miami. He had started his career in Public Service in the late 1990s, not lo
Cancer, what we can do about it. But the other component which is a longterm ambitious to be sure effort is this cohort of a million or more americans, which we could be studying for virtually all diseases and knowing that you are a dentist i would certainly include in that such things as periodontal disease. We know the environment and genetic risk are involved in those conditions. But we really havent had a sufficiently large study with appropriate patient participation to be able to get those answers. This should be a way to go there. So thats true for diabetes, for Heart Disease, for alzheimers disease, for virtually every common condition with a million people, youre going to have enough events you should really be able to dissect, what were the biomarkers that warned this would happen what were the environmental factors that played a role. We never had that power before we aim to get it. Thats fascinating stuff, and could really advance the advancement of diseases and cure diseas
Coming up on cspan3 the director of the National Institutes of health testifying before congress about how the nih spends its money. Then a Senate Banking Committee Hearing looking at whether beenal regulations should be eased for smaller banks. And later, a conversation on violent extremists traveling from europe to syria to join isis. You would see what used to call when i was a kid, a mutt and xbref combination or a stick paul set. Washington is was a large man. Six foot, very robust. Terrific natural athlete and madison is a skinny little guy. This sunday on q a, historian david o. Stewart on founding father james madson and the partnerships he made that aided in the success of our pledge ling nation. His i write most about is his ability to form remarkable partnerships with really the great people of his era but also alludes to his gift to the country of his talents and what he was able to do to create the first selfestablishing constitutional republic. Sunday night at 8 eastern a